Medroxyprogesterone Acetate

Medroxyprogesterone Acetate API (CAS No: 71-58-9) is produced by Amber Lifesciences Pvt. Ltd. in GMP and ISO 9001:2015 certified manufacturing facilities, ensuring high purity, stability, and safety for regulated pharmaceutical use. This Active Pharmaceutical Ingredient is supplied with full regulatory documentation, including a Certificate of Analysis (CoA) and Material Safety Data Sheet (MSDS), and complies with BP and USP pharmacopeial standards.

Medroxyprogesterone Acetate is commonly formulated in oral tablets and injectable suspensions used in hormonal therapies, including contraception, endometriosis, and menopausal symptom management. Each batch undergoes rigorous quality control testing to ensure global compliance and consistent therapeutic performance.

Amber Lifesciences supports pharmaceutical manufacturers, traders, and distributors across LATAM, Asia, Europe, and other international markets. With transparent supply chains, technical support, and reliable delivery, we help clients meet development and commercial goals with confidence.

Storage & Transportation:
Classified as non-dangerous goods. Store at 20°C to 25°C (68°F to 77°F), protected from light and moisture. Handle using standard practices to maintain stability.